NorthRock Partners LLC lowered its stake in Waters Corporation (NYSE:WAT – Free Report) by 10.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,050 shares of the medical instruments supplier’s stock after selling 124 shares during the period. NorthRock Partners LLC’s holdings in Waters were worth $366,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Olde Wealth Management LLC purchased a new position in Waters in the 1st quarter worth approximately $25,000. Zions Bancorporation National Association UT bought a new position in shares of Waters in the first quarter worth approximately $28,000. IFP Advisors Inc increased its stake in shares of Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after buying an additional 44 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in Waters during the 1st quarter valued at $41,000. Finally, Steph & Co. purchased a new stake in Waters during the 2nd quarter valued at $73,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.
Waters Price Performance
Shares of WAT stock opened at $332.86 on Thursday. The business’s fifty day moving average is $303.13 and its 200 day moving average is $323.52. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The stock has a market cap of $19.81 billion, a price-to-earnings ratio of 30.01, a PEG ratio of 3.11 and a beta of 1.04. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56.
Wall Street Analyst Weigh In
A number of research firms have issued reports on WAT. Bank of America boosted their price objective on shares of Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a research report on Thursday, June 26th. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a report on Saturday, July 26th. JPMorgan Chase & Co. increased their price objective on Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the stock a “hold” rating in a research report on Tuesday, August 5th. Finally, Wells Fargo & Company decreased their target price on Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a report on Tuesday, August 5th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $377.56.
View Our Latest Research Report on Waters
Waters Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Five stocks we like better than Waters
- Which Wall Street Analysts are the Most Accurate?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How Can Investors Benefit From After-Hours Trading
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 5 Top Rated Dividend Stocks to Consider
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.